Prolactinomas are a rare subset of brain tumors in pediatrics. We report a child with a prolactin secreting macroadenoma which was refractory to initial treatment with a dopamine antagonist. Given the location of her tumor she was ineligible for surgical resection. Temozolomide (200 mg/m2×5 days each month) was administered with a dramatic and prolonged response in tumor size, prolactin level, and symptoms, with no side effects from treatment. We demonstrate the benefit of temozolomide in the treatment of a pediatric patient with prolactinoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/jpem-2016-0159 | DOI Listing |
Publication Analysis
Top Keywords
child prolactin
8
prolactin secreting
8
secreting macroadenoma
8
successful treatment
4
treatment child
4
macroadenoma temozolomide
4
temozolomide prolactinomas
4
prolactinomas rare
4
rare subset
4
subset brain
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!